JPRN-jRCT2080223803尚未招募1 期
Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro (Humalog) Following Single Dose Administration in Japanese Patients With Type 1 Diabetes Mellitus
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Inclusion Criteria:
- •- Are Japanese male or female participant with a diagnosis of T1DM
- •- Have a body mass index (BMI) of 18.5 to 30.0 kilograms per square meter (kg/m2)
- •- Have a glycated hemoglobin <9.0%
排除标准
- •- Are receiving chronic systemic or inhaled glucocorticoid therapy, or have received such therapy before screening
- •- Have a history of renal impairment, or have a high serum creatinine level
- •- Have proliferative retinopathy or maculopathy and/or severe neuropathy; in particular, autonomic neuropathy based onophthalmologic examination
- •- Have had any significant changes in insulin regimen and/or unstable blood glucose control prior to screening
- •- Require daily insulin treatment >1.5 units per kilogram (U/kg)
研究者
相似试验
已完成
1 期
A Study of LY900014 Formulation in Healthy ParticipantsHealthyNCT02942654Eli Lilly and Company32
已完成
1 期
A Study of a New LY900014 Formulation in Healthy ParticipantsHealthyNCT02525744Eli Lilly and Company24
已完成
不适用
Pharmacokinetic and pharmacodynamic profile of midazolam intranasal spray in elderly volunteers.NL-OMON49143QPS Netherlands B.V.12
进行中（未招募）
1 期
A study of LY900014 compared to Humalog in children, adolescents and adults with Type 1 Diabetes MellitusDiabetes Mellitus, Type 1EUCTR2017-003220-78-DEEli Lilly and Company45
已完成
不适用
PHARMACOKINETICS AND METABOLISM OF 14C-LABELED GRC 4039 SODIUM FOLLOWING A SINGLE ORAL ADMINISTRATION IN HEALTHY MALE VOLUNTEERSNL-OMON37911Glenmark Pharmaceuticals SA6